Skip to main content
. 2019 Sep 17;20(18):4599. doi: 10.3390/ijms20184599

Figure 1.

Figure 1

Pentraxin-3 (PTX3_ overexpression reduces tumor growth. Tumors weight (A,B left panel) and representative tumors images (A,B right panel) at the end of the experiment in mock (A) and PTX3 (A) transfected MC17-51 injected subcutaneously (s.c.) in syngeneic C57BL/6 mice and in WT MC17-51 cells injected s.c. in wild type (C57BL/6) (B) and transgenic TgN(Tie2-hPTX3) (B) mice. PTX3 immunohistochemistry and morphometric analysis in mock (C) and PTX3 (D) transfected MC17-51 injected s.c. in syngeneic C57BL/6 mice and in WT MC17-51 cells injected s.c. in wild type (C57BL/6) (F) and transgenic TgN(Tie2-hPTX3) (G) mice. Morphometric analysis shows a significant decrease of PTX3 content in PTX3 (E) and TgN(Tie2-hPTX3) (H) compared to their respective controls. * p < 0.05. Scale bar: C, D, F, G 60 µm.